Largest Biotechnology Companies by Market Cap
The Biotechnology sector has 1,270 publicly listed stocks with a combined market cap of $1.89 Trillion. Vertex Pharmaceuticals Inc leads the sector with a market cap of $110.45 Billion. This ranking covers all Biotechnology stocks globally — from large-cap industry leaders to mid-cap and small-cap companies — ranked by market capitalization and updated daily.
Total Market Cap (USD)
$1.89 Trillion
Companies Listed
1,270
Largest Company
Vertex Pharmaceuticals Inc
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 1 |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX |
$110.45 Billion | $110.45 Billion | USA | $450.46 | +1.24% | +0.81% | 30.62 Million |
| 2 |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN |
$63.36 Billion | $63.36 Billion | USA | $614.98 | +0.46% | -3.22% | 26.94 Million |
| 3 |
UCB SA
BR:UCB |
$49.68 Billion | €42.50 Billion | Belgium | €259.20 | -5.71% | -0.69% | 5.47 Million |
| 4 |
Argen-X
BR:ARGX |
$47.14 Billion | €40.32 Billion | Belgium | €761.20 | -2.86% | -0.63% | 2.17 Million |
| 5 |
argenx NV ADR
NASDAQ:ARGX |
$45.97 Billion | $45.97 Billion | USA | $787.95 | -0.66% | -6.29% | 7.48 Million |
| 6 |
UCB S.A. UNSP.ADR 1/2
F:UNC0 |
$44.84 Billion | €38.35 Billion | Germany | €120.00 | -2.44% | -11.11% | 1.13K |
| 7 |
Argen-X
F:1AE |
$41.67 Billion | €35.64 Billion | Germany | €788.40 | +1.15% | +9.08% | 117.00 |
| 8 |
CSL LTD SPON.ADR 2
F:CSJA |
$40.06 Billion | €34.26 Billion | Germany | €18.20 | -3.19% | -9.90% | 420.00 |
| 9 |
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY |
$38.17 Billion | $38.17 Billion | USA | $287.80 | +1.75% | -5.03% | 24.31 Million |
| 10 |
CSL Ltd
AU:CSL |
$36.23 Billion | AU$51.20 Billion | Australia | AU$105.53 | -1.84% | +13.98% | 46.04 Million |
| 11 |
Revolution Medicines Inc
NASDAQ:RVMD |
$31.73 Billion | $31.73 Billion | USA | $160.06 | +4.02% | +7.26% | 63.90 Million |
| 12 |
Samsung Biologics Co Ltd
KO:207940 |
$31.37 Billion | ₩46.29 Trillion | Korea | ₩1000000.00 | +0.00% | +0.00% | 1.67 Million |
| 13 |
Celltrion Inc
KO:068270 |
$27.20 Billion | ₩40.13 Trillion | Korea | ₩175000.00 | +1.16% | +2.10% | 17.50 Million |
| 14 |
BeiGene Ltd.
F:49B |
$25.73 Billion | €22.01 Billion | Germany | €17.34 | +0.00% | +0.00% | 0.00 |
| 15 |
BeiGene, Ltd.
NASDAQ:ONC |
$25.45 Billion | $25.45 Billion | USA | $268.20 | +1.41% | -0.70% | 6.37 Million |
| 16 |
Royalty Pharma Plc
NASDAQ:RPRX |
$24.06 Billion | $24.06 Billion | USA | $54.27 | -1.09% | -2.86% | 93.50 Million |
| 17 |
Insmed Inc
NASDAQ:INSM |
$20.79 Billion | $20.79 Billion | USA | $97.46 | -0.40% | +3.44% | 95.50 Million |
| 18 |
Roivant Sciences Ltd
NASDAQ:ROIV |
$20.44 Billion | $20.44 Billion | USA | $30.03 | -0.03% | +5.07% | 148.56 Million |
| 19 |
BioNTech SE
F:22UA |
$20.05 Billion | €17.15 Billion | Germany | €78.05 | +0.39% | -0.26% | 11.54K |
| 20 |
Incyte Corporation
NASDAQ:INCY |
$20.04 Billion | $20.04 Billion | USA | $101.98 | -6.04% | -0.39% | 41.06 Million |
| 21 |
Moderna Inc
NASDAQ:MRNA |
$19.49 Billion | $19.49 Billion | USA | $52.13 | +4.45% | +9.89% | 135.79 Million |
| 22 |
Innovent Biologics Inc
F:6IB |
$16.76 Billion | €14.34 Billion | Germany | €8.30 | +2.28% | -3.76% | 200.00 |
| 23 |
Genmab A/S
CO:GMAB |
$15.36 Billion | Dkr98.19 Billion | Denmark | Dkr1594.00 | -1.54% | +0.66% | 4.55 Million |
| 24 |
Genmab AS
NASDAQ:GMAB |
$15.09 Billion | $15.09 Billion | USA | $24.58 | -1.99% | -2.27% | 44.97 Million |
| 25 |
GENMAB AS SP.ADR/1/10DK 1
F:GE91 |
$15.06 Billion | €12.88 Billion | Germany | €23.80 | +3.48% | -2.46% | 68.00 |
| 26 |
WUXI BIOLOGICS UNSP.ADR/2
F:1FW1 |
$14.75 Billion | €12.62 Billion | Germany | €7.20 | -2.04% | -9.43% | 42.00K |
| 27 |
WUXI BIOLOGICS-00000083
F:1FW2 |
$14.60 Billion | €12.49 Billion | Germany | €3.35 | +0.00% | -6.42% | 4.04K |
| 28 |
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ |
$14.17 Billion | $14.17 Billion | USA | $230.59 | +0.01% | -3.34% | 20.88 Million |
| 29 |
Ascendis Pharma AS
NASDAQ:ASND |
$13.79 Billion | $13.79 Billion | USA | $223.29 | +2.40% | +6.10% | 12.69 Million |
| 30 |
Axsome Therapeutics Inc
NASDAQ:AXSM |
$13.04 Billion | $13.04 Billion | USA | $253.40 | -0.69% | +9.07% | 15.02 Million |
| 31 |
BridgeBio Pharma Inc
NASDAQ:BBIO |
$13.03 Billion | $13.03 Billion | USA | $68.00 | +1.80% | +0.58% | 63.18 Million |
| 32 |
ALTEOGEN Inc
KQ:196170 |
$12.65 Billion | ₩18.67 Trillion | Korea | ₩349000.00 | +3.56% | +4.96% | 14.86 Million |
| 33 |
Ascendis Pharma AS
F:A71 |
$12.65 Billion | €10.82 Billion | Germany | €206.00 | +0.98% | +4.04% | 166.00 |
| 34 |
Exelixis Inc
NASDAQ:EXEL |
$12.17 Billion | $12.17 Billion | USA | $53.00 | -0.24% | +0.57% | 55.43 Million |
| 35 |
Ionis Pharmaceuticals Inc
NASDAQ:IONS |
$11.98 Billion | $11.98 Billion | USA | $73.96 | +0.93% | -0.70% | 40.24 Million |
| 36 |
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL |
$11.90 Billion | $11.90 Billion | USA | $518.74 | -1.97% | +0.03% | 8.60 Million |
| 37 |
Jazz Pharmaceuticals plc
F:J7Z |
$11.86 Billion | €10.14 Billion | Germany | €198.20 | -0.30% | -4.30% | 40.00 |
| 38 |
Avidity Biosciences, Inc
NASDAQ:RNAM |
$11.02 Billion | $11.02 Billion | USA | $71.34 | +0.00% | +0.00% | 0.00 |
| 39 |
Summit Therapeutics PLC
NASDAQ:SMMT |
$10.95 Billion | $10.95 Billion | USA | $14.13 | +0.86% | -4.33% | 140.60 Million |
| 40 |
AKESO INC. O.N.
F:4RY |
$10.89 Billion | €9.32 Billion | Germany | €10.12 | +5.34% | -9.36% | 6.20K |
| 41 |
Biomarin Pharmaceutical Inc
NASDAQ:BMRN |
$10.76 Billion | $10.76 Billion | USA | $55.65 | -0.54% | -1.97% | 55.40 Million |
| 42 |
Tubize-Fin
BR:TUB |
$10.23 Billion | €8.75 Billion | Belgium | €227.00 | -6.12% | -0.35% | 798.98K |
| 43 |
Cytokinetics Inc
NASDAQ:CYTK |
$9.59 Billion | $9.59 Billion | USA | $71.38 | +1.75% | -0.14% | 42.00 Million |
| 44 |
Krystal Biotech Inc
NASDAQ:KRYS |
$9.22 Billion | $9.22 Billion | USA | $324.75 | +2.13% | +7.89% | 6.14 Million |
| 45 |
Arrowhead Pharmaceuticals Inc
NASDAQ:ARWR |
$9.19 Billion | $9.19 Billion | USA | $77.15 | +3.53% | +5.55% | 34.78 Million |
| 46 |
Nuvalent Inc
NASDAQ:NUVL |
$9.07 Billion | $9.07 Billion | USA | $123.35 | +0.08% | +35.62% | 90.09 Million |
| 47 |
Verona Pharma plc
F:I9SA |
$9.07 Billion | €7.76 Billion | Germany | €90.20 | +0.67% | +0.22% | 2.25K |
| 48 |
ALK-Abelló A/S
CO:ALK-B |
$8.49 Billion | Dkr54.27 Billion | Denmark | Dkr269.60 | -0.30% | +1.28% | 4.00 Million |
| 49 |
Halozyme Therapeutics Inc
NASDAQ:HALO |
$8.38 Billion | $8.38 Billion | USA | $71.28 | +2.56% | -0.35% | 44.01 Million |
| 50 |
Blueprint Medicines Corp
NASDAQ:BPMC |
$8.36 Billion | $8.36 Billion | USA | $129.46 | +0.14% | +0.71% | 92.68 Million |
| 51 |
Bio-Techne Corp
NASDAQ:TECH |
$8.24 Billion | $8.24 Billion | USA | $56.17 | +4.02% | +8.04% | 70.32 Million |
| 52 |
Xizang Haisco Pharmaceutical Group Co Ltd
SHE:002653 |
$8.04 Billion | CN¥54.93 Billion | China | CN¥49.05 | -2.52% | +3.09% | 106.38 Million |
| 53 |
Abivax SA
PA:ABVX |
$7.89 Billion | €6.75 Billion | France | €85.10 | +0.06% | -3.13% | 11.84 Million |
| 54 |
Abivax SA American Depositary Shares
NASDAQ:ABVX |
$7.83 Billion | $7.83 Billion | USA | $98.26 | +1.77% | -3.22% | 54.98 Million |
| 55 |
Verona Pharma PLC ADR
NASDAQ:VRNA |
$7.31 Billion | $7.31 Billion | USA | $86.00 | +0.00% | -2.27% | 31.77 Million |
| 56 |
Vaxcyte Inc
NASDAQ:PCVX |
$7.16 Billion | $7.16 Billion | USA | $49.56 | +4.42% | +4.65% | 33.67 Million |
| 57 |
Praxis Precision Medicines Inc
NASDAQ:PRAX |
$7.08 Billion | $7.08 Billion | USA | $264.54 | -0.77% | +4.15% | 10.78 Million |
| 58 |
Cidara Therapeutics Inc
NASDAQ:CDTX |
$6.96 Billion | $6.96 Billion | USA | $221.38 | +0.03% | +0.26% | 24.25 Million |
| 59 |
Merus BV
NASDAQ:MRUS |
$6.83 Billion | $6.83 Billion | USA | $90.00 | -7.14% | -7.02% | 27.33 Million |
| 60 |
Arcellx Inc
NASDAQ:ACLX |
$6.73 Billion | $6.73 Billion | USA | $115.07 | +0.00% | +0.06% | 44.08 Million |
| 61 |
Spyre Therapeutics Inc.
NASDAQ:SYRE |
$6.64 Billion | $6.64 Billion | USA | $83.58 | +3.45% | +13.48% | 24.05 Million |
| 62 |
TG Therapeutics Inc
NASDAQ:TGTX |
$6.27 Billion | $6.27 Billion | USA | $50.30 | +1.58% | +25.25% | 45.87 Million |
| 63 |
Belite Bio Inc ADR
NASDAQ:BLTE |
$6.17 Billion | $6.17 Billion | USA | $164.45 | -1.77% | -2.55% | 3.65 Million |
| 64 |
Mirum Pharmaceuticals Inc
NASDAQ:MIRM |
$6.16 Billion | $6.16 Billion | USA | $101.00 | +1.67% | +8.04% | 23.65 Million |
| 65 |
PTC Therapeutics Inc
NASDAQ:PTCT |
$6.11 Billion | $6.11 Billion | USA | $76.77 | +2.17% | +8.17% | 29.70 Million |
| 66 |
Centessa Pharmaceuticals PLC ADR
NASDAQ:CNTA |
$6.10 Billion | $6.10 Billion | USA | $39.43 | -0.10% | -0.45% | 113.44 Million |
| 67 |
Kymera Therapeutics Inc
NASDAQ:KYMR |
$6.10 Billion | $6.10 Billion | USA | $85.59 | -0.71% | +15.46% | 12.73 Million |
| 68 |
Legend Biotech Corp
NASDAQ:LEGN |
$6.06 Billion | $6.06 Billion | USA | $35.48 | -1.09% | +8.77% | 66.07 Million |
| 69 |
Immunitybio Inc
NASDAQ:IBRX |
$5.96 Billion | $5.96 Billion | USA | $7.13 | +0.42% | +3.03% | 318.72 Million |
| 70 |
Immunovant Inc
NASDAQ:IMVT |
$5.91 Billion | $5.91 Billion | USA | $33.44 | -0.54% | +7.49% | 55.75 Million |
| 71 |
Rhythm Pharmaceuticals Inc
NASDAQ:RYTM |
$5.84 Billion | $5.84 Billion | USA | $89.70 | +1.49% | +3.82% | 15.06 Million |
| 72 |
Corcept Therapeutics Incorporated
NASDAQ:CORT |
$5.61 Billion | $5.61 Billion | USA | $83.12 | +0.25% | +14.46% | 24.56 Million |
| 73 |
Asymchem Laboratories Tian Jin Co Ltd
SHE:002821 |
$5.58 Billion | CN¥38.15 Billion | China | CN¥114.56 | -2.09% | -1.47% | 149.16 Million |
| 74 |
Shanghai Allist Pharmaceuticals Co. Ltd. A
SHG:688578 |
$5.58 Billion | CN¥38.12 Billion | China | CN¥84.70 | +1.99% | +0.49% | 115.14 Million |
| 75 |
Cogent Biosciences Inc
NASDAQ:COGT |
$5.38 Billion | $5.38 Billion | USA | $33.17 | +0.21% | +6.93% | 53.06 Million |
| 76 |
Apogee Therapeutics, Inc. Common Stock
NASDAQ:APGE |
$5.34 Billion | $5.34 Billion | USA | $86.19 | -2.42% | -0.84% | 23.70 Million |
| 77 |
3SBio Inc
F:83B |
$5.29 Billion | €4.52 Billion | Germany | €1.81 | +0.46% | +6.80% | 0.00 |
| 78 |
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SHG:603392 |
$5.25 Billion | CN¥35.86 Billion | China | CN¥28.36 | -3.93% | -15.57% | 136.36 Million |
| 79 |
Bachem Holding AG
SW:BANB |
$5.20 Billion | CHF4.11 Billion | Switzerland | CHF66.60 | +0.83% | -2.84% | 3.11 Million |
| 80 |
Protagonist Therapeutics Inc
NASDAQ:PTGX |
$5.09 Billion | $5.09 Billion | USA | $112.46 | +2.44% | +15.49% | 13.28 Million |
| 81 |
Caris Life Sciences, Inc. Common Stock
NASDAQ:CAI |
$5.09 Billion | $5.09 Billion | USA | $18.18 | +1.17% | +10.25% | 69.97 Million |
| 82 |
Crispr Therapeutics AG
NASDAQ:CRSP |
$5.07 Billion | $5.07 Billion | USA | $52.61 | +5.64% | +1.49% | 39.61 Million |
| 83 |
CG Oncology, Inc. Common stock
NASDAQ:CGON |
$5.03 Billion | $5.03 Billion | USA | $59.55 | -0.02% | +10.85% | 22.29 Million |
| 84 |
Pharmaron Beijing Co Ltd
SHE:300759 |
$4.86 Billion | CN¥33.18 Billion | China | CN¥22.47 | +0.40% | -2.60% | 666.37 Million |
| 85 |
Shanghai RAAS Blood Products Co Ltd Class A
SHE:002252 |
$4.79 Billion | CN¥32.73 Billion | China | CN¥4.93 | -1.60% | -5.01% | 1.04 Billion |
| 86 |
Sk Biopharmaceuticals Co Ltd
KO:326030 |
$4.79 Billion | ₩7.06 Trillion | Korea | ₩90200.00 | +2.62% | +2.38% | 11.33 Million |
| 87 |
Scholar Rock Holding Corp
NASDAQ:SRRK |
$4.68 Billion | $4.68 Billion | USA | $45.92 | +3.94% | +3.66% | 28.66 Million |
| 88 |
Amicus Therapeutics Inc
NASDAQ:FOLD |
$4.55 Billion | $4.55 Billion | USA | $14.49 | +0.00% | +0.21% | 59.70 Million |
| 89 |
CENTESSA PHARMACEUTICALS
F:260 |
$4.54 Billion | €3.88 Billion | Germany | €33.40 | -0.60% | -0.60% | 0.00 |
| 90 |
Akero Therapeutics Inc
NASDAQ:AKRO |
$4.50 Billion | $4.50 Billion | USA | $54.65 | +0.00% | +0.39% | 64.49 Million |
| 91 |
Dianthus Therapeutics Inc.
NASDAQ:DNTH |
$4.37 Billion | $4.37 Billion | USA | $82.51 | +0.54% | +2.48% | 20.44 Million |
| 92 |
Chongqing Zhifei Bio Products
SHE:300122 |
$4.33 Billion | CN¥29.59 Billion | China | CN¥12.36 | +0.00% | -0.64% | 497.50 Million |
| 93 |
Erasca Inc
NASDAQ:ERAS |
$4.17 Billion | $4.17 Billion | USA | $14.43 | +2.70% | +20.55% | 111.25 Million |
| 94 |
Metsera, Inc. Common Stock
NASDAQ:MTSR |
$4.12 Billion | $4.12 Billion | USA | $70.50 | +0.00% | -13.55% | 97.45 Million |
| 95 |
Celcuity LLC
NASDAQ:CELC |
$4.08 Billion | $4.08 Billion | USA | $88.24 | -0.35% | -0.05% | 39.36 Million |
| 96 |
Hebei Changshan Biochem Pharma
SHE:300255 |
$4.08 Billion | CN¥27.88 Billion | China | CN¥30.33 | -14.05% | -19.18% | 423.97 Million |
| 97 |
HLB Co. Ltd
KQ:028300 |
$4.05 Billion | ₩5.97 Trillion | Korea | ₩45500.00 | -1.30% | -10.08% | 20.13 Million |
| 98 |
Travere Therapeutics Inc
NASDAQ:TVTX |
$3.96 Billion | $3.96 Billion | USA | $53.80 | +3.38% | +17.44% | 46.81 Million |
| 99 |
Veradermics, Incorporated
NYSE:MANE |
$3.94 Billion | $3.94 Billion | USA | $96.27 | +0.21% | +5.00% | 10.19 Million |
| 100 |
Catalyst Pharmaceuticals Inc
NASDAQ:CPRX |
$3.83 Billion | $3.83 Billion | USA | $31.37 | +0.03% | +0.32% | 49.57 Million |
| 101 |
Crinetics Pharmaceuticals Inc
NASDAQ:CRNX |
$3.70 Billion | $3.70 Billion | USA | $35.12 | +1.89% | +6.68% | 23.34 Million |
| 102 |
Beijing Tiantan Biological Products Corp Ltd
SHG:600161 |
$3.68 Billion | CN¥25.13 Billion | China | CN¥12.71 | -1.24% | -2.00% | 288.76 Million |
| 103 |
Edgewise Therapeutics Inc
NASDAQ:EWTX |
$3.66 Billion | $3.66 Billion | USA | $35.21 | +1.09% | -1.07% | 30.57 Million |
| 104 |
ACADIA Pharmaceuticals Inc
NASDAQ:ACAD |
$3.64 Billion | $3.64 Billion | USA | $21.27 | +0.83% | -1.37% | 29.84 Million |
| 105 |
ABL Bio Inc
KQ:298380 |
$3.58 Billion | ₩5.29 Trillion | Korea | ₩95900.00 | +5.27% | -3.91% | 11.63 Million |
| 106 |
SpringWorks Therapeutics Inc
NASDAQ:SWTX |
$3.54 Billion | $3.54 Billion | USA | $46.99 | +0.02% | +0.06% | 44.43 Million |
| 107 |
Camurus AB
ST:CAMX |
$3.52 Billion | Skr32.68 Billion | Sweden | Skr548.00 | +1.67% | +0.09% | 4.25 Million |
| 108 |
Hualan Biological EngineeringInc
SHE:002007 |
$3.51 Billion | CN¥23.99 Billion | China | CN¥13.13 | -2.16% | -2.38% | 234.18 Million |
| 109 |
Suzhou Zelgen Biopharmaceuticals Co Ltd
SHG:688266 |
$3.49 Billion | CN¥23.87 Billion | China | CN¥90.19 | -2.90% | -0.53% | 89.55 Million |
| 110 |
NewAmsterdam Pharma Company N.V. Ordinary Shares
NASDAQ:NAMS |
$3.47 Billion | $3.47 Billion | USA | $30.60 | +0.66% | -2.92% | 29.45 Million |
| 111 |
Xiamen Amoytop Biotech Co Ltd
SHG:688278 |
$3.40 Billion | CN¥23.26 Billion | China | CN¥56.99 | -3.94% | +3.64% | 85.31 Million |
| 112 |
Tango Therapeutics Inc
NASDAQ:TNGX |
$3.39 Billion | $3.39 Billion | USA | $32.90 | +6.33% | +62.71% | 111.12 Million |
| 113 |
Shanghai Junshi Biosciences Co Ltd
SHG:688180 |
$3.38 Billion | CN¥23.12 Billion | China | CN¥30.20 | -1.60% | +0.27% | 366.13 Million |
| 114 |
Zealand Pharma A/S
CO:ZEAL |
$3.37 Billion | Dkr21.55 Billion | Denmark | Dkr306.00 | +3.45% | -6.22% | 13.64 Million |
| 115 |
Viking Therapeutics Inc
NASDAQ:VKTX |
$3.35 Billion | $3.35 Billion | USA | $29.63 | +3.06% | +4.15% | 45.82 Million |
| 116 |
Denali Therapeutics Inc
NASDAQ:DNLI |
$3.30 Billion | $3.30 Billion | USA | $22.22 | +2.59% | +13.83% | 42.54 Million |
| 117 |
LegoChem Biosciences Inc
KQ:141080 |
$3.28 Billion | ₩4.83 Trillion | Korea | ₩132800.00 | +2.79% | -2.42% | 11.52 Million |
| 118 |
Genscript Biotech Corporation
F:G51 |
$3.27 Billion | €2.80 Billion | Germany | €1.28 | -3.03% | -8.57% | 0.00 |
| 119 |
TELIX Pharmaceuticals Ltd
AU:TLX |
$3.27 Billion | AU$4.62 Billion | Australia | AU$13.79 | +1.40% | +6.98% | 46.60 Million |
| 120 |
Xenon Pharmaceuticals Inc
NASDAQ:XENE |
$3.24 Billion | $3.24 Billion | USA | $52.40 | +0.58% | +1.30% | 31.46 Million |
| 121 |
Beam Therapeutics Inc
NASDAQ:BEAM |
$3.20 Billion | $3.20 Billion | USA | $31.12 | +7.20% | +5.85% | 45.68 Million |
| 122 |
Arcus Biosciences Inc
NYSE:RCUS |
$3.04 Billion | $3.04 Billion | USA | $24.18 | +1.60% | +4.27% | 21.99 Million |
| 123 |
Dyne Therapeutics Inc
NASDAQ:DYN |
$2.96 Billion | $2.96 Billion | USA | $18.73 | +2.97% | +9.92% | 34.23 Million |
| 124 |
Relay Therapeutics Inc
NASDAQ:RLAY |
$2.95 Billion | $2.95 Billion | USA | $14.96 | +1.01% | +10.65% | 107.25 Million |
| 125 |
Alumis Inc
NASDAQ:ALMS |
$2.83 Billion | $2.83 Billion | USA | $23.00 | -4.76% | +20.67% | 26.38 Million |
| 126 |
Structure Therapeutics Inc. American Depositary Shares
NASDAQ:GPCR |
$2.78 Billion | $2.78 Billion | USA | $43.07 | +0.33% | +14.61% | 16.87 Million |
| 127 |
Soleno Therapeutics Inc
NASDAQ:SLNO |
$2.76 Billion | $2.76 Billion | USA | $53.01 | +0.00% | +0.11% | 48.81 Million |
| 128 |
Ligand Pharmaceuticals Incorporated
NASDAQ:LGND |
$2.69 Billion | $2.69 Billion | USA | $253.25 | -0.90% | +6.86% | 4.59 Million |
| 129 |
Arcutis Biotherapeutics Inc
NASDAQ:ARQT |
$2.65 Billion | $2.65 Billion | USA | $25.58 | +4.92% | +20.49% | 42.84 Million |
| 130 |
Disc Medicine Inc.
NASDAQ:IRON |
$2.61 Billion | $2.61 Billion | USA | $70.09 | +3.09% | +4.61% | 10.74 Million |
| 131 |
BrightGene Bio Medical Technology C
SHG:688166 |
$2.61 Billion | CN¥17.81 Billion | China | CN¥42.10 | -4.38% | -10.99% | 260.15 Million |
| 132 |
Tarsus Pharmaceuticals Inc
NASDAQ:TARS |
$2.55 Billion | $2.55 Billion | USA | $61.85 | -0.16% | +4.34% | 11.77 Million |
| 133 |
Kailera Therapeutics, Inc. Common Stock
NASDAQ:KLRA |
$2.54 Billion | $2.54 Billion | USA | $19.67 | +4.13% | +1.55% | 10.28 Million |
| 134 |
Ultragenyx
NASDAQ:RARE |
$2.50 Billion | $2.50 Billion | USA | $25.38 | +4.23% | +15.84% | 35.17 Million |
| 135 |
BB Biotech AG
SW:BION |
$2.48 Billion | CHF1.96 Billion | Switzerland | CHF43.60 | +0.23% | +3.32% | 1.65 Million |
| 136 |
Ideaya Biosciences Inc
NASDAQ:IDYA |
$2.47 Billion | $2.47 Billion | USA | $30.23 | +4.31% | +6.86% | 24.76 Million |
| 137 |
Enliven Therapeutics Inc.
NASDAQ:ELVN |
$2.46 Billion | $2.46 Billion | USA | $42.36 | -8.17% | +22.04% | 32.24 Million |
| 138 |
Vera Therapeutics Inc
NASDAQ:VERA |
$2.46 Billion | $2.46 Billion | USA | $34.24 | -0.06% | +6.04% | 25.04 Million |
| 139 |
Adaptive Biotechnologies Corp
NASDAQ:ADPT |
$2.43 Billion | $2.43 Billion | USA | $17.46 | -0.80% | +3.31% | 50.11 Million |
| 140 |
BioArctic AB (publ)
ST:BIOA-B |
$2.36 Billion | Skr21.96 Billion | Sweden | Skr295.80 | -2.18% | -3.96% | 4.99 Million |
| 141 |
SOLENO THERAPEUT. DL-001
F:6XC |
$2.31 Billion | €1.97 Billion | Germany | €44.86 | +1.70% | +1.20% | 130.00 |
| 142 |
KEYMED BIOSCIENCES -0001
F:64Z |
$2.28 Billion | €1.95 Billion | Germany | €6.65 | +4.72% | +4.72% | 0.00 |
| 143 |
Celldex Therapeutics Inc
NASDAQ:CLDX |
$2.24 Billion | $2.24 Billion | USA | $32.12 | +2.72% | +12.23% | 17.30 Million |
| 144 |
89bio Inc
NASDAQ:ETNB |
$2.20 Billion | $2.20 Billion | USA | $14.84 | +0.00% | +0.27% | 140.50 Million |
| 145 |
Sinocelltech Group Ltd
SHG:688520 |
$2.20 Billion | CN¥15.06 Billion | China | CN¥33.81 | -2.14% | -4.49% | 56.52 Million |
| 146 |
Bavarian Nordic
CO:BAVA |
$2.19 Billion | Dkr13.99 Billion | Denmark | Dkr182.60 | -0.81% | +0.00% | 4.84 Million |
| 147 |
Pharma Reaserch Prod Co Ltd
KQ:214450 |
$2.14 Billion | ₩3.15 Trillion | Korea | ₩303500.00 | +5.02% | +5.93% | 2.46 Million |
| 148 |
Definium Therapeutics, Inc.
NASDAQ:DFTX |
$2.14 Billion | $2.14 Billion | USA | $23.77 | -3.96% | +0.93% | 47.72 Million |
| 149 |
SK Bioscience Co Ltd
KO:302440 |
$2.13 Billion | ₩3.15 Trillion | Korea | ₩40100.00 | +2.30% | +0.38% | 4.02 Million |
| 150 |
Nektar Therapeutics
NASDAQ:NKTR |
$2.06 Billion | $2.06 Billion | USA | $61.15 | +2.97% | +6.67% | 22.21 Million |
Track real-time market capitalization of largest public companies in the Biotechnology industry. Compare marketcap, analyze stock performance, and discover leading biotechnology corporations. View all industries